SCHEMBL4965174

SCHEMBL4965174

CNC1Oc2cc(Cl)cc(-c3cccc(OC)c3OC)c2O1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.37
LMNA P02545 2/20 0.37
GAA P10253 2/20 0.35
HSD17B10 Q99714 4/20 0.35
ALDH1A1 P00352 4/20 0.35
MAPT P10636 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
P2RX7 Q99572 1/20 0.35
NR3C1 P04150 2/20 0.35
HTR7 P34969 1/20 0.34
PGR P06401 1/20 0.34
NR3C2 P08235 1/20 0.34
TUBB4A P04350 2/20 0.34
TUBB P07437 2/20 0.34
TUBA3C P0DPH7 2/20 0.34
TUBA1B P68363 2/20 0.34
TUBA4A P68366 2/20 0.34
TUBB4B P68371 2/20 0.34
TUBB3 Q13509 2/20 0.34
TUBB2A Q13885 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6105743 0.89 HTR7 (0.41) ALDH1A1NR3C1HTR7
SCHEMBL6104341 0.83 ALDH1A1 (0.40) KDM4EHSD17B10ALDH1A1MAPTTDP1
SCHEMBL4961210 0.82 HTR7 (0.39) KDM4EALDH1A1MAPTHTR7ADRA1D
SCHEMBL4965160 0.80 GAA (0.37) KDM4ELMNAGAAHSD17B10ALDH1A1
SCHEMBL4961868 0.80 CYP2D6 (0.36) KDM4ELMNAHSD17B10ALDH1A1MAPT
SCHEMBL4961068 0.77 GPBAR1 (0.34) KDM4EHSD17B10ALDH1A1NPC1RAB9A
SCHEMBL4963826 0.76 HTR2A (0.33) ALDH1A1HPGD
SCHEMBL4961206 0.74 ADRA1D (0.43) KDM4ELMNAALDH1A1ADRA1DADRA1A
SCHEMBL4961201 0.74 ADRA1D (0.43) KDM4ELMNAALDH1A1ADRA1DADRA1A
SCHEMBL4964630 0.74 SCN10A (0.34) KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101218223-A Benzodioxane and benzodioxolane derivatives and uses thereof WYETH CORP (US) 2008-07-09 CN disclosed
EP-1871759-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF Wyeth a Corporation of the State of Delaware (US) 2008-01-02 EP disclosed
WO-2006116158-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF WYETH (US) 2006-11-02 WO disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof HTR2C, HTR1D, HTR1A KDM4E 2229/4885LMNA 2921/4885GAA 4052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.